Abstract Avila, Jesús, José J. Lucas, Mar Pérez, and Félix Hernández. Role of Tau Protein in
Both Physiological and Pathological Conditions. Physiol Rev 84: 361–384, 2004; …

The accumulation of α-synuclein aggregates is the hallmark of Parkinson's disease, and
more generally of synucleinopathies. The accumulation of tau aggregates however is …

Frontotemporal lobar degeneration (FTLD) is a clinically and pathologically heterogeneous
syndrome, characterized by progressive decline in behaviour or language associated with …

A clinically and pathologically heterogeneous type of frontotemporal lobar degeneration has
abnormal tau pathology in neurons and glia (FTLD-tau). Familial FTLD-tau is usually due to …

A working group supported by the Office of Rare Diseases of the National Institutes of Health
formulated neuropathologic criteria for corticobasal degeneration (CBD) that were …

Frontotemporal lobar degeneration (FTLD) comprises two main classes of
neurodegenerative diseases characterized by neuronal/glial proteinaceous inclusions (ie …

We assessed the prevalence of common altered brain proteins in 296 cognitively
unimpaired subjects ranging from age 50 to 102 years. The incidence and the stage of …

Filamentous tau pathologies are hallmark lesions of several neurodegenerative tauopathies
including Alzheimer's disease (AD) and corticobasal degeneration (CBD) which show cell …

Now in a thoroughly revised and updated Sixth Edition, Localization in Clinical Neurology is
cornerstone in clinical neurology. Designed to aid clinicians in their quest to locate the …

Parkinson disease (PD) is the second most common neurodegenerative disorder. In most
instances, PD is thought to result from a complex interaction between multiple genetic and …